Table 3 KEGG enrichment summary
GEO accession | ID | Description | p.adjust | qvalue | Count |
|---|---|---|---|---|---|
GSE13355 | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 1.13E-09 | 9.21E-10 | 10 |
hsa04060 | Cytokine-cytokine receptor interaction | 1.88E-06 | 1.53E-06 | 11 | |
hsa04062 | Chemokine signaling pathway | 3.62E-06 | 2.94E-06 | 9 | |
hsa04657 | IL-17 signaling pathway | 3.62E-06 | 2.94E-06 | 7 | |
hsa05164 | Influenza A | 0.001870867 | 0.001518523 | 6 | |
hsa04622 | RIG-I-like receptor signaling pathway | 0.003759724 | 0.003051647 | 4 | |
hsa05160 | Hepatitis C | 0.008015124 | 0.006505618 | 5 | |
hsa05146 | Amoebiasis | 0.011253432 | 0.009134047 | 4 | |
hsa04620 | Toll-like receptor signaling pathway | 0.011253432 | 0.009134047 | 4 | |
hsa05171 | Coronavirus disease—COVID-19 | 0.029315198 | 0.0237942 | 5 | |
hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 0.029315198 | 0.0237942 | 3 | |
GSE30999 | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 0.000671079 | 0.000591225 | 5 |
hsa05323 | Rheumatoid arthritis | 0.003891546 | 0.003428479 | 4 | |
hsa04657 | IL-17 signaling pathway | 0.003891546 | 0.003428479 | 4 | |
hsa04060 | Cytokine-cytokine receptor interaction | 0.027838544 | 0.024525948 | 5 | |
hsa04062 | Chemokine signaling pathway | 0.034931897 | 0.030775241 | 4 | |
hsa05146 | Amoebiasis | 0.039637888 | 0.034921252 | 3 | |
hsa04064 | NF-kappa B signaling pathway | 0.039637888 | 0.034921252 | 3 |